Tender

PHE - Corporate - Prescribed Medicines Review

PUBLIC HEALTH ENGLAND

This public procurement record has 2 releases in its history.

TenderAmendment

24 Sep 2018 at 13:25

Tender Notice
Tender

19 Sep 2018 at 14:34

Tender Notice
Summary of the contracting process

Public Health England is currently conducting an open tender titled "PHE - Corporate - Prescribed Medicines Review," aimed at evaluating prescribed drugs that may cause dependence. The tender is focused on the administrative healthcare services industry and is based in London, England. The tender period is set to conclude on 2nd October 2018, while the contract itself is expected to commence on 8th October 2018 and conclude by 30th November 2018. Businesses interested in this opportunity must provide data on prescribed medicines issued within care homes in England or dispensed via private prescriptions, with a maximum contract value of £12,200, excluding VAT.

This tender presents significant opportunities for businesses specialising in data collection and analysis, particularly those with access to comprehensive datasets on prescribed medications. Small and medium-sized enterprises (SMEs) that can deliver relevant data insights and demonstrate value for money will be well-positioned to compete for this contract. Companies with expertise in healthcare analytics, pharmaceuticals, or data management are encouraged to apply, ensuring to provide a detailed breakdown of costs and the ability to supply requested information by the specified deadlines.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

PHE - Corporate - Prescribed Medicines Review

Notice Description

PHE is conducting a review of the evidence on prescribed drugs that may cause dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines. Additional information: PHE is seeking an organisation with control of existing datasets that include information on the volume of prescribed medicines in the UK, and able to supply data on the volume (by unit) for each of the drugs included in the review that were: 1. issued within care homes in England; or 2. dispensed on private prescriptions from retail pharmacies. The data would be required by country within the UK (England, Wales, Scotland, Northern Ireland) for the period March 2013 until April 2018 provided in monthly, quarterly and annual illustrations delivered as a single data extract by 30th November 2018. Costs The overall contract value will be a maximum of PS12,200 (excluding VAT). A detailed breakdown of costs is required, which will need to demonstrate value for money. How to apply Email details of the raw data you are able to provide and quote with breakdown of costs to Michael.Griffin@phe.gov.uk Drug class (for this analysis) BNF chapter Drugs included Opioids 4.7.2 Buprenorphine Codeine* Dextromoramide Diamorphine Dihydrocodeine** Dipipanone (including with cyclizine) Fentanyl Hydromorphone Meptazinol Methadone Morphine (including with cyclizine) Oxycodone (including with naloxone) Papaveretum Pentazocine Pentazocine Pethidine Tapentadol Tramadol (including with paracetamol) 4.7.1 Codeine with paracetamol = co-codamol* Dihydrocodeine with paracetamol = co-dydramol** Z-drugs 4.1.1 Zaleplon Zopiclone Zolpidem Benzodiazepines 4.1.1 (insomnia) Flurazepam Loprazolam Lormetazepam Nitrazepam Temazepam 4.1.2 (anxiety) Diazepam Chlordiazepoxide Lorazepam Oxazepam Gabapentinoids 4.7.3 Gabapentin 4.8.1 Pregabalin Antidepressants 4.3.1 (Tricyclics) Amitriptyline (including with perphenazine) Amoxapine Clomipramine Dosulepin Doxepin Imipramine Lofepramine Maprotiline Mianserin Nortriptyline Protriptyline Trazodone Trimipramine 4.3.2 (MAOIs) Isocarboxazid Moclobemide Phenelzine Tranylcypromine 4.3.3 (SSRIs) Citalopram Escitalopram Fluoxetine Fluvoxamine Paroxetine Sertraline 4.3.4 (Other antidepressants) Agomelatine Duloxetine Flupentixol Mirtazapine Nefazodone Oxitriptan Reboxetine Tryptophan Venlafaxine Vortioxetine

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-89051353-844f-4466-9f85-f44527571494
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c052945b-a4f5-4cf2-b874-94168c2f8d47
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure (below threshold)
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

75 - Administration, defence and social security services

CPV Codes

75122000 - Administrative healthcare services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
24 Sep 20187 years ago
Submission Deadline
2 Oct 2018Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
7 Oct 2018 - 30 Nov 2018 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
PUBLIC HEALTH ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Post Town
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-89051353-844f-4466-9f85-f44527571494-2018-09-24T14:25:45+01:00",
    "date": "2018-09-24T14:25:45+01:00",
    "ocid": "ocds-b5fd17-89051353-844f-4466-9f85-f44527571494",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "tender_190043/713406",
        "title": "PHE - Corporate - Prescribed Medicines Review",
        "description": "PHE is conducting a review of the evidence on prescribed drugs that may cause dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines. Additional information: PHE is seeking an organisation with control of existing datasets that include information on the volume of prescribed medicines in the UK, and able to supply data on the volume (by unit) for each of the drugs included in the review that were: 1. issued within care homes in England; or 2. dispensed on private prescriptions from retail pharmacies. The data would be required by country within the UK (England, Wales, Scotland, Northern Ireland) for the period March 2013 until April 2018 provided in monthly, quarterly and annual illustrations delivered as a single data extract by 30th November 2018. Costs The overall contract value will be a maximum of PS12,200 (excluding VAT). A detailed breakdown of costs is required, which will need to demonstrate value for money. How to apply Email details of the raw data you are able to provide and quote with breakdown of costs to Michael.Griffin@phe.gov.uk Drug class (for this analysis) BNF chapter Drugs included Opioids 4.7.2 Buprenorphine Codeine* Dextromoramide Diamorphine Dihydrocodeine** Dipipanone (including with cyclizine) Fentanyl Hydromorphone Meptazinol Methadone Morphine (including with cyclizine) Oxycodone (including with naloxone) Papaveretum Pentazocine Pentazocine Pethidine Tapentadol Tramadol (including with paracetamol) 4.7.1 Codeine with paracetamol = co-codamol* Dihydrocodeine with paracetamol = co-dydramol** Z-drugs 4.1.1 Zaleplon Zopiclone Zolpidem Benzodiazepines 4.1.1 (insomnia) Flurazepam Loprazolam Lormetazepam Nitrazepam Temazepam 4.1.2 (anxiety) Diazepam Chlordiazepoxide Lorazepam Oxazepam Gabapentinoids 4.7.3 Gabapentin 4.8.1 Pregabalin Antidepressants 4.3.1 (Tricyclics) Amitriptyline (including with perphenazine) Amoxapine Clomipramine Dosulepin Doxepin Imipramine Lofepramine Maprotiline Mianserin Nortriptyline Protriptyline Trazodone Trimipramine 4.3.2 (MAOIs) Isocarboxazid Moclobemide Phenelzine Tranylcypromine 4.3.3 (SSRIs) Citalopram Escitalopram Fluoxetine Fluvoxamine Paroxetine Sertraline 4.3.4 (Other antidepressants) Agomelatine Duloxetine Flupentixol Mirtazapine Nefazodone Oxitriptan Reboxetine Tryptophan Venlafaxine Vortioxetine",
        "datePublished": "2018-09-19T15:34:54+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "75122000",
            "description": "Administrative healthcare services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    },
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure (below threshold)",
        "tenderPeriod": {
            "endDate": "2018-10-02T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2018-10-08T00:00:00+01:00",
            "endDate": "2018-11-30T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/c052945b-a4f5-4cf2-b874-94168c2f8d47",
                "datePublished": "2018-09-24T14:25:45+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-82416",
            "name": "Public Health England",
            "identifier": {
                "legalName": "Public Health England"
            },
            "address": {
                "streetAddress": "Wellington House, 133-155 Waterloo Road",
                "locality": "London",
                "postalCode": "SE1 8UG",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Michael Griffin",
                "email": "Michael.Griffin@phe.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-82416",
        "name": "Public Health England"
    }
}